Your browser doesn't support javascript.
loading
Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study.
Toyoda, Masao; Murata, Takashi; Saito, Nobumichi; Kimura, Moritsugu; Takahashi, Hiroo; Ishida, Naoto; Kitamura, Makoto; Hida, Miho; Hayashi, Akinori; Moriguchi, Ibuki; Kobayashi, Naoyuki; Tsuriya, Daisuke; Sakao, Yukitoshi; Matsushita, Takaya; Ito, Yukie; Suzuki, Shota; Kasama, Shu; Kasahara, Masato; Yamakawa, Tadashi; Mori, Katsuhito; Kuroda, Akio; Miura, Junnosuke; Hirota, Yushi; Abe, Masanori; Fukagawa, Masafumi; Sakane, Naoki; Hosoda, Kiminori.
Afiliação
  • Toyoda M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Murata T; Diabetes Center, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Saito N; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Kimura M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Takahashi H; Jinken Clinic, Kanagawa, Japan.
  • Ishida N; Seichi Clinic, Kanagawa, Japan.
  • Kitamura M; Kurata Hospital, Kanagawa, Japan.
  • Hida M; Kurata Hospital, Kanagawa, Japan.
  • Hayashi A; Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Kanagawa, Japan.
  • Moriguchi I; Sohbudai Nieren Clinic, Kanagawa, Japan.
  • Kobayashi N; Sohbudai Nieren Clinic, Kanagawa, Japan.
  • Tsuriya D; 2nd Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Sakao Y; Hamana Clinic, Shizuoka, Japan.
  • Matsushita T; Department of Diabetology, Endocrinology and Metabolism, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Ito Y; Bioethics Supervisory Office, Nara Medical University Hospital, Nara, Japan.
  • Suzuki S; Institute for Clinical and Translational Science, Nara Medical University Hospital, Nara, Japan.
  • Kasama S; Institute for Clinical and Translational Science, Nara Medical University Hospital, Nara, Japan.
  • Kasahara M; Institute for Clinical and Translational Science, Nara Medical University Hospital, Nara, Japan.
  • Yamakawa T; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama, Japan.
  • Mori K; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kuroda A; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Miura J; Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Hirota Y; Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Abe M; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Sakane N; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Osaka, Japan.
Ther Apher Dial ; 25(5): 586-594, 2021 Oct.
Article em En | MEDLINE | ID: mdl-33403763
ABSTRACT
FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty-one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute relative difference and mean absolute difference were 23.4% and 33.9 mg/dL, respectively. Sensor glucose levels and capillary glucose levels were significantly correlated (r = 0.858, P < .01), although the sensor glucose levels were significantly lower than the capillary glucose levels. The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage. The percentage of sensor results in Zones A and B in the consensus error grid analysis and in the Clarke error grid analysis were 99.7% and 99.0%, respectively. Its insufficient accuracy necessitates adjunct usage of FreeStyle Libre with self-monitoring of blood glucose in patients undergoing HD.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Automonitorização da Glicemia / Diálise Renal / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Ther Apher Dial Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Automonitorização da Glicemia / Diálise Renal / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Ther Apher Dial Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão